RE: Genedrive to surge to 30-40p range within 2 weeks13 Dec 2022 11:23
That money is for research, not AIHL. States it quite clearly. That said it’s undeniable that this area of research and medical care is coming sharply into focus now so should be good for GDR. It’ll just be our luck that Budd and his sales team botch things up and take too long and hey presto there’s competition from elsewhere. I’ve no confidence in Budd at all to make GDR commercially viable so am placing all my hopes on a buyout. Then we’ll see these products used and placed worldwide, but sadly it won’t be GDR and its share holders that see the really huge rewards.
Buyout offer 68p